Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

The CMS has finalized the first cycle of drug price negotiations under the IRA, establishing precedent for improved ...

At-home gut microbiome tests are trending, selling insights to the curious, empowerment to the chronically ill and a claimed path to longevity to the wellness-conscious. Private companies are offering ...

A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and ...

This Journal of Clinical Investigation review describes how glucagon-like peptide-1 (GLP-1)–based medicines reduce systemic and tissue inflammation through both weight-dependent and weight-independent ...

During National Diabetes Month, we recognize the millions of Americans living with diabetes and we renew our commitment to building a healthier Nation.

People with type 2 diabetes who took low-dose aspirin were less likely to have a heart attack or stroke, University of Pittsburgh researchers reported.